It would have been for The Lancet Oncology, but it turns out the journal forgot that it had already reviewed the play when it was in New York, so no need for a Manchester review now.
@fizzy.bleach
The journal does pay for content, I think £150 for a one page (700 word) review, and cost of the ticket provided as well. So if anyone sees anything oncology related showing in Manchester, feel free to pitch it.
It would have been for The Lancet Oncology, but it turns out the journal forgot that it had already reviewed the play when it was in New York, so no need for a Manchester review now.
@fizzy.bleach
The journal does pay for content, I think £150 for a one page (700 word) review, and cost of the ticket provided as well. So if anyone sees anything oncology related showing in Manchester, feel free to pitch it.